Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study of Sacituzumab Govitecan-hziy in Metastatic Urothelial Cancer

Multiple Cancer Types

The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy in participants with metastatic urothelial cancer (mUC).
Bladder, Urologic
II
Davis, Nancy
NCT03547973
VICCURO18120

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: